Evidence map›Paper›PMID 40759734›Full record

ArticleHNO2025

[Otorhinolaryngologic diseases during lactation-which medications are compatible with breastfeeding?]

Wolfgang E Paulus, Carolin Schwamborn, Ulrike Friebe-Hoffmann

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in HNO, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wolfgang E PaulusKlinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Ulm, Ulm, Deutschland. paulus@reprotox.de.
Carolin SchwambornKlinik für Hals-Nasen-Ohrenheilkunde und Kopf-Hals-Chirurgie, Universitätsklinikum Ulm, Ulm, Deutschland.
Ulrike Friebe-HoffmannKlinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Ulm, Ulm, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breastmilk is well established as the best source of nutrition for infants. Any interruption to breastfeeding comes with risks such as mastitis, decreased breastmilk supply, infant bottle refusal, and infant allergic reaction if formula is used. The majority of common medications used in general otolaryngology are safe for breastfeeding patients. Insufficient knowledge can lead to clinicians and patients alike being concerned about continued breastfeeding, resulting in interruption or cessation of breastfeeding. On the other hand, much-needed treatment is often withheld for fear of putting the infant at risk from contaminated breastmilk, which can disrupt the mother's wellbeing and, in turn, disturb a successful breastfeeding relationship. The aim of the present work is to present a structured "guideline for practice" pertaining to medication that can be used during lactation for treating medical conditions of the ear, nose, and throat.

Indexed as

Breast FeedingLactationOtolaryngologyOtorhinolaryngologic DiseasesPractice Guidelines as TopicEvidence-Based MedicineFemaleGermanyHumansInfantInfant, NewbornInfantInfant careMilk, humanOtorhinolaryngologic diseasesPharmacotherapy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.